Amgen discloses data breach involving patient health information
Amgen, the global biotechnology company, has disclosed a data breach that exposed patient health information. The company has not yet released detailed information about the scope or timeline of the incident.
Why this matters: Health data is not like a leaked password you can reset. It follows people permanently — through insurance decisions, employment, and personal relationships. Amgen is one of the largest biotech companies in the world, which means this breach likely touches patients managing serious conditions like cancer or chronic disease. These are people who had no real choice but to share that information. The key questions now are how many patients were affected, how long the data was exposed, and what Amgen is actually doing to protect the people it put at risk.
Who should care: Cybersecurity · Privacy officers · Administrators · Healthcare professionals · Compliance
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.